
Gonorrhea is a sexually transmitted disease caused by the bacterium Neisseria gonorrhoeae and can affect both genders. It is a common infection, especially among young people aged between 15 years to 24 years. According to the U.S. Centers for Disease Control and Prevention (CDC), gonorrhea is the second most commonly reported disease in the United States affecting approximately 800,000 people each year. In the United Kingdom, about 28,000 cases of gonorrhea are reported each year. Symptoms of gonorrhea in men encompass painful urination, swelling of testicles and pus discharge. In women, symptoms comprise excessive vaginal discharge, painful urination and abdominal pain. Complications include ectopic pregnancy, Pelvic Inflammatory Disease (PID) and Epididymitis. The incubation period for this disease also varies between men and women. In men, the symptoms occur between 2 to 14 days whereas in women it takes 7 days to 21 days to show symptoms. Astonishingly, about 50% of women have no symptoms in the early stage and during pregnancy it may infect the fetus during delivery.
Highlights
The global Gonorrhea Diagnostics market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
There has been a recent rise in the incidences of gonorrhea across the globe due to the adoption of risky sexual behavior and unsafe sexual practices. According to the CDC, gonorrhea is the second most commonly reported communicable disease after chlamydia. The highest occurrence rates of gonorrhea are primarily in heterosexually infected men, especially those aged 25-34 years. These increasing incidences of gonorrhea will enhance the demand for gonorrhea diagnostic products during the forecast period.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Gonorrhea Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gonorrhea Diagnostics.
The Gonorrhea Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Gonorrhea Diagnostics market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gonorrhea Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Abbott Laboratories
Beckman Coulter
Roche Diagnostics
Siemens
²ú¾±´Ç²Ñé°ù¾±±ð³Ü³æ
PerkinElmer
Ortho Clinical Diagnostics
Segment by Type
Chromatography
Diagnostic Imaging
Differential Light Scattering
Flow Cytometry
Gel Microdroplets
Immunoassay
Molecular Diagnostics
Monoclonal Antibodies Test
Segment by Application
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gonorrhea Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gonorrhea Diagnostics Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Chromatography
1.2.3 Diagnostic Imaging
1.2.4 Differential Light Scattering
1.2.5 Flow Cytometry
1.2.6 Gel Microdroplets
1.2.7 Immunoassay
1.2.8 Molecular Diagnostics
1.2.9 Monoclonal Antibodies Test
1.3 Market by Application
1.3.1 Global Gonorrhea Diagnostics Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Diagnostic Centers
1.3.5 Clinics
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gonorrhea Diagnostics Market Perspective (2018-2029)
2.2 Gonorrhea Diagnostics Growth Trends by Region
2.2.1 Global Gonorrhea Diagnostics Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Gonorrhea Diagnostics Historic Market Size by Region (2018-2023)
2.2.3 Gonorrhea Diagnostics Forecasted Market Size by Region (2024-2029)
2.3 Gonorrhea Diagnostics Market Dynamics
2.3.1 Gonorrhea Diagnostics Industry Trends
2.3.2 Gonorrhea Diagnostics Market Drivers
2.3.3 Gonorrhea Diagnostics Market Challenges
2.3.4 Gonorrhea Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gonorrhea Diagnostics Players by Revenue
3.1.1 Global Top Gonorrhea Diagnostics Players by Revenue (2018-2023)
3.1.2 Global Gonorrhea Diagnostics Revenue Market Share by Players (2018-2023)
3.2 Global Gonorrhea Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Gonorrhea Diagnostics Revenue
3.4 Global Gonorrhea Diagnostics Market Concentration Ratio
3.4.1 Global Gonorrhea Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gonorrhea Diagnostics Revenue in 2022
3.5 Gonorrhea Diagnostics Key Players Head office and Area Served
3.6 Key Players Gonorrhea Diagnostics Product Solution and Service
3.7 Date of Enter into Gonorrhea Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Gonorrhea Diagnostics Breakdown Data by Type
4.1 Global Gonorrhea Diagnostics Historic Market Size by Type (2018-2023)
4.2 Global Gonorrhea Diagnostics Forecasted Market Size by Type (2024-2029)
5 Gonorrhea Diagnostics Breakdown Data by Application
5.1 Global Gonorrhea Diagnostics Historic Market Size by Application (2018-2023)
5.2 Global Gonorrhea Diagnostics Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Gonorrhea Diagnostics Market Size (2018-2029)
6.2 North America Gonorrhea Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Gonorrhea Diagnostics Market Size by Country (2018-2023)
6.4 North America Gonorrhea Diagnostics Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gonorrhea Diagnostics Market Size (2018-2029)
7.2 Europe Gonorrhea Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Gonorrhea Diagnostics Market Size by Country (2018-2023)
7.4 Europe Gonorrhea Diagnostics Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gonorrhea Diagnostics Market Size (2018-2029)
8.2 Asia-Pacific Gonorrhea Diagnostics Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Gonorrhea Diagnostics Market Size by Region (2018-2023)
8.4 Asia-Pacific Gonorrhea Diagnostics Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gonorrhea Diagnostics Market Size (2018-2029)
9.2 Latin America Gonorrhea Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Gonorrhea Diagnostics Market Size by Country (2018-2023)
9.4 Latin America Gonorrhea Diagnostics Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gonorrhea Diagnostics Market Size (2018-2029)
10.2 Middle East & Africa Gonorrhea Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Gonorrhea Diagnostics Market Size by Country (2018-2023)
10.4 Middle East & Africa Gonorrhea Diagnostics Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Gonorrhea Diagnostics Introduction
11.1.4 Abbott Laboratories Revenue in Gonorrhea Diagnostics Business (2018-2023)
11.1.5 Abbott Laboratories Recent Development
11.2 Beckman Coulter
11.2.1 Beckman Coulter Company Detail
11.2.2 Beckman Coulter Business Overview
11.2.3 Beckman Coulter Gonorrhea Diagnostics Introduction
11.2.4 Beckman Coulter Revenue in Gonorrhea Diagnostics Business (2018-2023)
11.2.5 Beckman Coulter Recent Development
11.3 Roche Diagnostics
11.3.1 Roche Diagnostics Company Detail
11.3.2 Roche Diagnostics Business Overview
11.3.3 Roche Diagnostics Gonorrhea Diagnostics Introduction
11.3.4 Roche Diagnostics Revenue in Gonorrhea Diagnostics Business (2018-2023)
11.3.5 Roche Diagnostics Recent Development
11.4 Siemens
11.4.1 Siemens Company Detail
11.4.2 Siemens Business Overview
11.4.3 Siemens Gonorrhea Diagnostics Introduction
11.4.4 Siemens Revenue in Gonorrhea Diagnostics Business (2018-2023)
11.4.5 Siemens Recent Development
11.5 ²ú¾±´Ç²Ñé°ù¾±±ð³Ü³æ
11.5.1 ²ú¾±´Ç²Ñé°ù¾±±ð³Ü³æ Company Detail
11.5.2 ²ú¾±´Ç²Ñé°ù¾±±ð³Ü³æ Business Overview
11.5.3 ²ú¾±´Ç²Ñé°ù¾±±ð³Ü³æ Gonorrhea Diagnostics Introduction
11.5.4 ²ú¾±´Ç²Ñé°ù¾±±ð³Ü³æ Revenue in Gonorrhea Diagnostics Business (2018-2023)
11.5.5 ²ú¾±´Ç²Ñé°ù¾±±ð³Ü³æ Recent Development
11.6 PerkinElmer
11.6.1 PerkinElmer Company Detail
11.6.2 PerkinElmer Business Overview
11.6.3 PerkinElmer Gonorrhea Diagnostics Introduction
11.6.4 PerkinElmer Revenue in Gonorrhea Diagnostics Business (2018-2023)
11.6.5 PerkinElmer Recent Development
11.7 Ortho Clinical Diagnostics
11.7.1 Ortho Clinical Diagnostics Company Detail
11.7.2 Ortho Clinical Diagnostics Business Overview
11.7.3 Ortho Clinical Diagnostics Gonorrhea Diagnostics Introduction
11.7.4 Ortho Clinical Diagnostics Revenue in Gonorrhea Diagnostics Business (2018-2023)
11.7.5 Ortho Clinical Diagnostics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Abbott Laboratories
Beckman Coulter
Roche Diagnostics
Siemens
²ú¾±´Ç²Ñé°ù¾±±ð³Ü³æ
PerkinElmer
Ortho Clinical Diagnostics
Ìý
Ìý
*If Applicable.
